Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
18F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
Kebir S, Gaertner FC, Mueller M, Nelles M, Simon M, Schäfer N, Stuplich M, Schaub C, Niessen M, Mack F, Bundschuh R, Greschus S, Essler M, Glas M, Herrlinger U. Kebir S, et al. Among authors: glas m. Oncol Lett. 2016 Mar;11(3):2195-2198. doi: 10.3892/ol.2016.4189. Epub 2016 Feb 4. Oncol Lett. 2016. PMID: 26998148 Free PMC article.
Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status.
Kurzwelly D, Glas M, Roth P, Weimann E, Lohner H, Waha A, Schabet M, Reifenberger G, Weller M, Herrlinger U. Kurzwelly D, et al. Among authors: glas m. J Neurooncol. 2010 May;97(3):389-92. doi: 10.1007/s11060-009-0032-0. Epub 2009 Oct 20. J Neurooncol. 2010. PMID: 19841864 Free article.
Non-enhancing primary CNS lymphoma.
Lachenmayer ML, Blasius E, Niehusmann P, Kovacs A, Stuplich M, Eichler O, Glas M, Urbach H, Herrlinger U. Lachenmayer ML, et al. Among authors: glas m. J Neurooncol. 2011 Jan;101(2):343-4. doi: 10.1007/s11060-010-0258-x. Epub 2010 Jun 9. J Neurooncol. 2011. PMID: 20532953 No abstract available.
Residual tumor cells are unique cellular targets in glioblastoma.
Glas M, Rath BH, Simon M, Reinartz R, Schramme A, Trageser D, Eisenreich R, Leinhaas A, Keller M, Schildhaus HU, Garbe S, Steinfarz B, Pietsch T, Steindler DA, Schramm J, Herrlinger U, Brüstle O, Scheffler B. Glas M, et al. Ann Neurol. 2010 Aug;68(2):264-9. doi: 10.1002/ana.22036. Ann Neurol. 2010. PMID: 20695020 Free PMC article.
Bevacizumab-induced regression of anaplastic meningioma.
Puchner MJA, Hans VH, Harati A, Lohmann F, Glas M, Herrlinger U. Puchner MJA, et al. Among authors: glas m. Ann Oncol. 2010 Dec;21(12):2445-2446. doi: 10.1093/annonc/mdq634. Epub 2010 Nov 1. Ann Oncol. 2010. PMID: 21041375 Free article. No abstract available.
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
Glas M, Bähr O, Felsberg J, Rasch K, Wiewrodt D, Schabet M, Simon M, Urbach H, Steinbach JP, Rieger J, Fimmers R, Bamberg M, Nägele T, Reifenberger G, Weller M, Herrlinger U; Neuro-Oncology Group of the German Cancer Society. Glas M, et al. Ann Neurol. 2011 Sep;70(3):445-53. doi: 10.1002/ana.22478. Epub 2011 Jun 27. Ann Neurol. 2011. PMID: 21710625 Clinical Trial.
191 results